Assessing the potential causal effects of 1099 plasma metabolites on 2099 binary disease endpoints
- PMID: 40155430
- PMCID: PMC11953310
- DOI: 10.1038/s41467-025-58129-2
Assessing the potential causal effects of 1099 plasma metabolites on 2099 binary disease endpoints
Abstract
Metabolites are small molecules that are useful for estimating disease risk and elucidating disease biology. Here, we perform two-sample Mendelian randomization to systematically infer the potential causal effects of 1099 plasma metabolites measured in 6136 Finnish men from the METSIM study on risk of 2099 binary disease endpoints measured in 309,154 Finnish individuals from FinnGen. We find evidence for 282 putative causal effects of 70 metabolites on 183 disease endpoints. We also identify 25 metabolites with potential causal effects across multiple disease domains, including ascorbic acid 2-sulfate affecting 26 disease endpoints in 12 disease domains. Our study suggests that N-acetyl-2-aminooctanoate and glycocholenate sulfate affect risk of atrial fibrillation through two distinct metabolic pathways and that N-methylpipecolate may mediate the putative causal effect of N6,N6-dimethyllysine on anxious personality disorder.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: E.B.F. is an employee and stockholder of Pfizer. The remaining authors declare no competing interests.
Figures




Update of
-
Metabolome-wide Mendelian randomization characterizes heterogeneous and shared causal effects of metabolites on human health.medRxiv [Preprint]. 2023 Jun 29:2023.06.26.23291721. doi: 10.1101/2023.06.26.23291721. medRxiv. 2023. Update in: Nat Commun. 2025 Mar 28;16(1):3039. doi: 10.1038/s41467-025-58129-2. PMID: 37425837 Free PMC article. Updated. Preprint.
References
-
- Wishart, D. S. Metabolomics for investigating physiological and pathophysiological processes. Physiol. Rev.99, 1819–1875 (2019). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical